354512-22-4

Basic information

• Product Name: 3-METHOXY-5-NITROBENZALDEHYDE
• Synonyms: 3-METHOXY-5-NITROBENZALDEHYDE
• CAS NO: 354512-22-4
• Molecular Formula: C₈H₇NO₄
• Molecular Weight: 181.14548
• Mol File: 354512-22-4.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 326.5 °C at 760 mmHg
• Flash Point: 165.4 °C
• Appearance: /
• Density: 1.322 g/cm³
• Vapor Pressure: 0.000215mmHg at 25°C
• Refractive Index: 1.59
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 3-METHOXY-5-NITROBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-METHOXY-5-NITROBENZALDEHYDE(354512-22-4)
• EPA Substance Registry System: 3-METHOXY-5-NITROBENZALDEHYDE(354512-22-4)

Safety Data

• Hazardous Substances Data: 354512-22-4(Hazardous Substances Data)

Usage

General Description

3-Methoxy-5-nitrobenzaldehyde is a chemical compound with the molecular formula C8H7NO4. It is a yellow solid with a strong odor, and it is commonly used in the pharmaceutical and dye industries. 3-METHOXY-5-NITROBENZALDEHYDE is often employed as an intermediate in the synthesis of various pharmaceuticals and organic compounds. It is also used as a reagent in organic synthesis and as a starting material for the preparation of other benzaldehyde derivatives. Additionally, 3-methoxy-5-nitrobenzaldehyde is known for its antibacterial and antifungal properties, and it has potential applications in the development of new drugs and biologically active compounds.

InChI:InChI=1/C8H7NO4/c1-13-8-3-6(5-10)2-7(4-8)9(11)12/h2-5H,1H3

Upstream product

• 2702-58-1 methyl 3,5-dinitrobenzoate 
• 33224-19-0 3-methoxy-5-nitrobenzonitrile 
• 78238-13-8 3-methoxy-5-nitrobenzoic acid methyl ester 
• 78238-12-7 3-methoxy-5-nitrobenzoic acid 
• 99-34-3 3,5-dinitrobenzoic acid 
• 354525-36-3 (3-methoxy-5-nitrophenyl)methanol 

Downstream Products

• 1325235-97-9 (4R,7E)-10-(3-methoxy-5-(non-8-enamido)phenyl)-7-methyldeca-1,7-dien-4-yl (2S)-2-(cyclohexanecarboxamido)propanoate 
• 1325235-98-0 (4R,7E)-10-(3-methoxy-5-(non-8-enamido)phenyl)-7-methyldeca-1,7-dien-4-yl 2-(cyclohexanecarboxamido)acetate 
• 1325235-99-1 (4R,7E)-10-(3-methoxy-5-(non-8-enamido)phenyl)-7-methyldeca-1,7-dien-4-yl (2R)-2-acetamidopropanoate 
• 1325236-01-8 (4R,7E)-10-(3-methoxy-5-(non-8-enamido)phenyl)-7-methyldeca-1,7-dien-4-yl (2R)-2-(cyclopentanecarboxamido)propanoate 
• 1325236-02-9 (4R,7E)-10-(3-methoxy-5-(non-8-enamido)phenyl)-7-methyldeca-1,7-dien-4-yl (2R)-2-(cyclohexanecarboxamido)-3-methylbutanoate 
• 1325236-03-0 (4R,7E)-10-(3-methoxy-5-(non-8-enamido)phenyl)-7-methyldeca-1,7-dien-4-yl (2R)-2-(cyclohexanecarboxamido)-4-methylpentanoate 
• 1325236-04-1 (4R,7E)-10-(3-methoxy-5-(non-8-enamido)phenyl)-7-methyldeca-1,7-dien-4-yl (2R)-2-(cyclohexanecarboxamido)-3-phenylpropanoate 
• 1325235-67-3 C₁₀H₁₃NO₄ 
• 1325235-69-5 3-(3-amino-5-methoxyphenyl)propan-1-ol 
• 1325235-70-8 N-(3-(3-hydroxypropyl)-5-methoxyphenyl)non-8-enamide 
• 1325235-75-3 (S,E)-N-(3-(7-hydroxy-4-methyldeca-3,9-dien-1-yl)-5-methoxyphenyl)non-8-enamide 
• 1325235-76-4 (R)-(R,E)-10-(3-methoxy-5-(non-8-enamido)phenyl)-7-methyldeca-1,7-dien-4-yl 2-(cyclohexanecarboxamido)propanoate 
• 1325235-78-6 (4R,7Z)-10-(3-methoxy-5-(non-8-enamido)phenyl)-7-methyldeca-1,7-dien-4-yl (2R)-2-(cyclohexanecarboxamido)propanoate 
• 1325235-93-5 N-(3-(3-iodopropyl)-5-methoxyphenyl)non-8-enamide 

Relevant articles and documents

Structure-activity relationship of 7-aryl-2-anilino-pyrrolopyrimidines as Mer and Axl tyrosine kinase inhibitors

The TAM (Axl, Mer, and Tyro3) family is implicated in the survival and chemoresistance of tumours and has emerged as a potential therapeutic target. A novel series of 7-aryl-2-anilino-pyrrolopyrimidines were identified as potent Axl/Mer tyrosine kinase in

PHENYL-UREA AND PHENYL-CARBAMATE DERIVATIVES AS INHIBITORS OF PROTEIN AGGREGATION

The present invention relates to certain phenyl-urea and phenyl-carbamate derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for preventing, reversing, slowing, or inhibiting protein aggregation, and methods of treating diseases that are associated with protein aggregation, including neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, Lewy body disease, and multiple system atrophy.

Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents

A new series of 3-aminobenzophenone compounds as potent inhibitors of tubulin polymerization was discovered based on the mimic of the aminocombretastatin molecular skeleton. Lead compounds 5 and 11, with alkoxy groups at the C-4 position of B-ring, were p